-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Nykode Therapeutics - Grant of share options
01 Jul 2024 20:20 CEST
Issuer
NYKODE THERAPEUTICS ASA
Oslo, Norway, July 1, 2024 - A total of 3,159,019 share options have been
granted to employees of Nykode Therapeutics ASA under the company’s share option
scheme, of which 1,232,460 share options have been granted to primary insiders.
The share options will have a strike price of NOK 15.35 per share, have a
five-year term and will vest equally over a four-year vesting period.
Please see further details in attached document.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Nykode Therapeutics ASA
Provider
Oslo Børs Newspoint
Company Name
NYKODE THERAPEUTICS ASA
ISIN
NO0010714785
Symbol
NYKD
Market
Euronext Oslo Børs